SEC Form 4 · accession 0001127602-19-008790
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 9:23 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | S | 100 | $140.33 | D | 20,120 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.35 | D | 20,020 | D | |
| Common Stock | Feb 26, 2019 | S | 117 | $140.39 | D | 19,903 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.42 | D | 19,803 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.50 | D | 19,703 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.60 | D | 19,603 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.78 | D | 19,503 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $141.34 | D | 19,403 | D | |
| Common Stock | Feb 26, 2019 | S | 200 | $141.35 | D | 19,203 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $141.73 | D | 19,103 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $141.98 | D | 19,003 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $143.10 | D | 18,903 | D | |
| Common Stock | Feb 26, 2019 | S | 70 | $143.14 | D | 18,833 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $143.67 | D | 18,733 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $143.84 | D | 18,633 | D | |
| Common Stock | Feb 27, 2019 | F | 218 | $140.57 | D | 18,415 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.